{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:11:53Z","timestamp":1764828713825,"version":"3.37.3"},"reference-count":5,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.2337\/dci19-0037","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T01:29:33Z","timestamp":1574299773000},"page":"e188-e188","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":3,"title":["Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088\u20131094"],"prefix":"10.2337","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-9502","authenticated-orcid":false,"given":"Sascha","family":"Pilemann-Lyberg","sequence":"first","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Gentofte, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine Willum","family":"Hansen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Gentofte, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Gentofte, Denmark"},{"name":"University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"2022031300531831100_B1","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.2337\/dc19-1321","article-title":"Comment on Pilemann-Lyberg et al. Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes. Diabetes Care 2019;42:1088\u20131094 (Letter)","volume":"42","author":"Chen","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031300531831100_B2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/dc18-2173","article-title":"Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes","volume":"42","author":"Pilemann-Lyberg","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031300531831100_B3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ndt\/gfy076","article-title":"Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes","volume":"34","author":"Pilemann-Lyberg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2022031300531831100_B4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/db09-0014","article-title":"Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study","volume":"58","author":"Hovind","year":"2009","journal-title":"Diabetes"},{"key":"2022031300531831100_B5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2337\/dc19-0342","article-title":"Preventing Early Renal Loss in Diabetes (PERL) study: a randomized double-blinded trial of allopurinol\u2014rationale, design, and baseline data","volume":"42","author":"Afkarian","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/12\/e188\/528821\/dci190037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/12\/e188\/528821\/dci190037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:23:06Z","timestamp":1647145386000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/12\/e188\/36252\/Response-to-Comment-on-Pilemann-Lyberg-et-al-Uric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,11,12]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0037","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2019,11,12]]}}}